Hernia mesh lawsuits are putting several device makers under scrutiny as patients report pain, infection, recurrence, organ injury, and revision surgery after hernia repair. The cases do not focus on one company or one product. Instead, litigation has spread across manufacturers, with claims involving design defects, warnings, product failure, recalls, and disputed settlement values.
Bard and Davol Face the Largest Litigation Wave
Bard and Davol remain at the center of one of the largest hernia mesh proceedings in the country. Federal cases involving Bard and Davol polypropylene hernia mesh products have been centralized in multidistrict litigation in the Southern District of Ohio under MDL No. 2846 (source). The lawsuits have involved claims that certain polypropylene mesh products caused injuries such as chronic pain, infection, organ perforation, migration, and other complications (source).
Settlement activity has made this litigation especially important for patients. A reported agreement exceeded $1 billion and was said to resolve more than 38,000 lawsuits involving claims that patients suffered organ damage from surgical mesh used in hernia repair (source). The company later disclosed that it had reached an agreement to resolve the vast majority of existing Bard hernia litigation, with confidential terms and no admission of liability or wrongdoing (source).
Covidien Claims Focus on Parietex Mesh Products
Covidien, now part of Medtronic, is another major defendant in hernia mesh litigation. Federal cases involving Covidien hernia mesh products are centralized in Massachusetts under MDL No. 3029 (source). The litigation has included claims involving Parietex mesh products, with allegations tied to mesh failure, infections, and other complications after hernia repair (source).
The Covidien cases remain closely watched because they are less resolved than the Bard litigation. A recent litigation update listed more than 2,400 pending Covidien cases and noted that bellwether trials were scheduled for 2026 (source). Bellwether trials can help both sides test evidence, but they do not automatically decide every patient’s case.
Atrium C-QUR Cases Center on Coating and Complications
Atrium Medical Corporation has faced lawsuits involving its C-QUR mesh products. These cases have been centralized in New Hampshire under MDL No. 2753 (source). The litigation has focused on claims involving C-QUR mesh and alleged injuries such as adhesions, infection, migration, bowel obstruction, organ perforation, bleeding, and rejection (source).
C-QUR claims are different from some other hernia mesh lawsuits because they have included scrutiny of the product’s coating. Some litigation summaries describe C-QUR as using an omega-3 fish oil coating and state that claims have centered on whether the design or coating contributed to complications (source). Atrium-related settlement reporting has also described a $66 million settlement framework connected to C-QUR claims (source).
What Patients Need to Prove
The manufacturer name alone is not enough to establish a claim. Patients usually need records showing which mesh was implanted, when symptoms began, what doctors found, whether revision surgery was needed, and what damages followed. The operative report, implant sticker, imaging, revision notes, medical bills, and wage records can all matter.
The type of lawsuit may also vary by manufacturer and product. Some cases are handled in federal MDLs, some settle confidentially, and others may be reviewed individually. A patient with Bard mesh may face a different legal path than someone with Covidien, Atrium, or another product.
Scrutiny Depends on Product-Specific Evidence
Lawsuits for hernia mesh have placed multiple device makers under scrutiny, but the claims are not identical. Bard and Davol cases have focused heavily on polypropylene mesh injuries and large-scale settlement activity. Covidien cases remain active around Parietex products. Atrium claims have involved C-QUR mesh and coating questions.
For patients, the next step is documentation. A strong claim starts with identifying the device, building a medical timeline, recording complications, and preserving proof of financial loss. Manufacturer scrutiny may explain why lawsuits exist, but patient-specific records usually determine whether a claim can move forward.